Bruno Nicolás Falcone

Bruno Nicolás Falcone

Auto-generated profile, based on publicly available information

Bruno Nicolás Falcone

School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Chemistry of Materials
Verified
Journal Article
Open access
MAMostafa Ahmadi
Mostafa Ahmadi
FPFarhad Panahi
Farhad Panahi
NBNaeimeh Bahri-Laleh
Naeimeh Bahri-Laleh
MSMohammad Sabzi
Mohammad Sabzi
GPGerard Pareras
Gerard Pareras
Poater AlbertPoater Albert
Poater Albert

1 April 2014 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
JCJohn Comer
John Comer
SJSam Judge
Sam Judge
DMDarren Matthews
Darren Matthews
LTLouise Towers
Louise Towers
BFBruno Falcone
Bruno Falcone
JDJohn Dearden
John Dearden
The intrinsic aqueous solubility of indomethacin

27 April 2007 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
MMMarcelo A. Marti
Marcelo A. Marti
LCLuciana Capece
Luciana Capece
DBDamián E. Bikiel
Damián E. Bikiel
BFBruno Falcone
Bruno Falcone
DEDario Estrin
Dario Estrin

6 February 2016 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
JRJuan Rodriguez
Juan Rodriguez
BFBruno N. Falcone
Bruno N. Falcone
SSSergio Szajnman
Sergio Szajnman
Introduction: Farnesyl pyrophosphate synthase (FPPS) catalyzes the condensation of isopentenyl diphosphate with dimethylallyl diphosphate to give rise to one molecule of geranyl diphosphate, which ...

19 July 2016 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
JRJuan Rodriguez
Juan Rodriguez
BFBruno N. Falcone
Bruno N. Falcone
SSSergio Szajnman
Sergio Szajnman
Introduction: Trypanosoma cruzi is the etiologic agent of American trypanosomiasis (Chagas disease), which is one of the important parasitic diseases worldwide. The number of infected people with T. cruzi diminished from 18 million in 1991 to 6 million in 2010, but it is still the most prevalent parasitic disease in the Americas. The existing chemotherapy is still deficient and based on two drugs: nifurtimox and benznidazole, which are not FDA-approved in the United States. Areas covered: This review covers the current and future directions of Chagas disease chemotherapy based on drugs that interfere with relevant metabolic pathways. This article also illustrates the challenges of diagnosis, which in recent infections, is only detected when the parasitemia is high (direct detection); whereas, in the chronic phase is reached after multiple serological tests. Expert opinion: The current chemotherapy is associated with long term treatments and severe side effects. Nifurtimox and benznidazole are able to cure at least 50% of recent infections. Nevertheless, they suffer from major drawbacks: selective drug sensitivity on different T. cruzi strains and serious side effects. The aim of this review is focused on presenting an up-to-date status of the chemotherapy and diagnosis.

15 November 2018 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
BFBruno Nicolás Falcone
Bruno Nicolás Falcone
MGMatthew N. Grayson
Matthew N. Grayson
JRJuan Rodriguez
Juan Rodriguez
The first catalytic enantioselective pinacol rearrangement was reported by Antilla and co-workers in 2010. The reaction was catalyzed by a chiral phosphoric acid and resulted in high levels of enantioselectivity (up to 96% ee). The present study uses Density Functional Theory to investigate the mechanism and origins of stereoselectivity of this important reaction and to explain the difference in selectivity between different catalysts. An OH···O hydrogen bond between the intermediate indolyl alcohol and the phosphate group from the catalyst together with a CH···O hydrogen bond between the indole and the phosphate group were observed in the preferred activation mode for the stereodetermining [1,2]-aryl shift. A stronger CH···O interaction in the major transition state was found to contribute to the high levels of enantioselectivity. A more bulky catalyst (TRIP) was found to impede the formation of the key CH···O interaction, leading to lower levels of enantioselectivity.